Vera Therapeutics, Inc. (VERA:NASDAQ) closed at $28.63 on October 27, 2026, up 1.17% on the day. The stock trades 48.9% below its 52-week high of $56.05 and 24.2% above its 52-week low of $23.05. Over the past year, it lost 6.9%. Vera Therapeutics, Inc. is part of the Health Care sector.
In 252 trading sessions since October 24, 2025, VERA closed higher on 111 days (44%). Its best day was November 10, 2025 (+14.72%) and its worst was November 3, 2025 (-8.85%). The stock moved 10% or more in a single session 5 times.
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
Find more stocks like VERA with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.